Granules India informs about press release

22 Oct 2020 Evaluate

Granules India has informed that it has enclosed the press release on 22 October 2020 titled ‘Granules India receives approval for Generic “K-Dur,” equivalent to Klor Con M, potassium chloride tablets for the treatment of Hypokalemia’. This is for the information and dissemination to the members of the exchange.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

544.40 -16.25 (-2.90%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×